Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Medical Castration	NCIT_C15743
In Vivo	NCIT_C15744	[Located or occurring in the body.]
Hyperfractionation	NCIT_C15745
Remission Induction Therapy	NCIT_C15746
Total Nodal Irradiation	NCIT_C15748
Extensive Radiation	NCIT_C16230	[Cancer therapy using ionizing radiation to a significant (>50%) portion of the body, e.g. craniospinal, total body irradiation, or pelvic radiation.]
Tumor Debulking	NCIT_C15749	[The surgical removal of as much of a malignant tumor as is reasonably possible. This procedure increases the effectiveness of the subsequent administration of chemotherapy and/or radiation therapy.]
Cytoreductive Surgery	NCIT_C132068	[A surgical procedure that refers to the removal of as many malignant cells as possible from an anatomic site affected by cancer.]
Compartmental Treatment	NCIT_C16174
Chemoembolization	NCIT_C15752	[A procedure that introduces chemotherapy to blood vessels adjacent to a tumor, for the purpose of both treating the tumor and interrupt blood flow to the tumor, which serves both to trap the chemotherapeutic agent at the tumor and to decrease the amount of nutrients flowing to the tumor.]
Embolization Therapy	NCIT_C15230	[A procedure in which substances are injected into blood vessels adjacent to a tumor for the purpose of interrupting the blood flow to the cancer cells.]
Cancer Registry	NCIT_C15753	[Cancer registries gather a wide variety of specific information on cancer patients that can be analyzed to identify health disparity trends in cancer incidence, mortality and patient survival.]
Population Database	NCIT_C16126	[Example: SEER and other cancer registries]
Geographic Information System	NCIT_C15754	[A system of hardware, software, and geographic data designed to capture, store, update, manipulate, analyze and display data that are linked to location.]
Database	NCIT_C15426	[An information set with a regular structure. Although it can be applied to any set of information the term was invented to refer to computerized data, and is used almost exclusively in computing.]
Lumpectomy	NCIT_C15755	[The surgical removal of a discrete mass.]
VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820	NCIT_C49090	[An orally bioavailable, small molecule receptor tyrosine kinase inhibitor with potential antineoplastic activity. XL820 binds to and inhibits the receptor tyrosine kinases for vascular endothelial growth factor (VEGF), c-kit, and platelet-derived growth factor (PDGF). In tumor models of breast carcinomas, gliomas, and leukemia, this agent exhibits dose-dependent growth inhibition and has been shown to cause tumor regression.]
Plk1 Inhibitor BI 2536	NCIT_C49091	[A small molecule compound with potential antineoplastic activities. BI 2536 binds to and inhibits Polo-like kinase 1 (Plk1), resulting in mitotic arrest, disruption of cytokinesis, and apoptosis in susceptible tumor cell populations. Plk1, a serine/threonine-protein kinase, is a key regulator of multiple processes fundamental to mitosis and cell division.]
Mitotic Enzyme Modulator	NCIT_C67443	[A class of compounds that modulate the activity of mitotic enzymes. Mitotic enzymes regulate various mitotic events including centrosome separation, mitotic spindle assembly, chromosome alignment, phosphorylation of tubulin and cell-cycle regulators, and interaction with mitotic kinesins; other roles include facilitating the progression through and the exit from mitosis as well as regulating cytokinesis. Agents that modulate the activity of mitotic enzymes, specifically those that inhibit cytokinesis, may produce an anti-mitotic effect resulting from the aberrant formation of abnormal or polyploid cells and their subsequent exit from mitosis, which triggers apoptosis-an effect unrelated to the classical mitotic arrest described with other anti-mitotic compounds.]
Melanoma of the Ciliary Body and Choroid pT3a TNM Finding v7	NCIT_C88697	[Tumor size category 3 without ciliary body involvement and extraocular extension. (from AJCC 7th Ed.)]